SCHEMBL3114133

SCHEMBL3114133

O=c1c2[nH]c(Cl)nc2n(CCn2cccc2)c(=O)n1CCCCc1nc(-c2ccccn2)no1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.43
SMN1; SMN2 Q16637 7/20 0.43
RAB9A P51151 6/20 0.43
ALDH1A1 P00352 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
ADORA2B P29275 9/20 0.40
AR P10275 1/20 0.38
ADORA1 P30542 6/20 0.38
ADORA2A P29274 4/20 0.38
ADORA3 P0DMS8 4/20 0.38
TP53 P04637 2/20 0.38
TSHR P16473 2/20 0.38
NFKB1 P19838 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
S1PR1 P21453 1/20 0.37
AKR1B1 P15121 1/20 0.37
HTT P42858 2/20 0.36
MAPT P10636 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3111410 0.97 NPC1 (0.43) NPC1SMN1; SMN2RAB9AALDH1A1NPSR1
SCHEMBL1067151 0.90 NPC1 (0.45) NPC1SMN1; SMN2RAB9AALDH1A1NPSR1
SCHEMBL836978 0.90 ADORA2B (0.46) NPC1SMN1; SMN2RAB9AALDH1A1NPSR1
SCHEMBL837624 0.90 ADORA2B (0.49) NPC1SMN1; SMN2RAB9AADORA2BADORA1
SCHEMBL3115399 0.89 NPC1 (0.51) NPC1SMN1; SMN2RAB9AALDH1A1NPSR1
SCHEMBL3114981 0.89 NPC1 (0.53) NPC1SMN1; SMN2RAB9AALDH1A1NPSR1
SCHEMBL1070506 0.88 NPC1 (0.46) NPC1SMN1; SMN2RAB9AALDH1A1NPSR1
SCHEMBL836881 0.88 ADORA2B (0.46) NPC1SMN1; SMN2RAB9AALDH1A1NPSR1
SCHEMBL837093 0.88 ADORA2B (0.43) NPC1SMN1; SMN2RAB9AALDH1A1NPSR1
SCHEMBL836439 0.88 NPC1 (0.43) NPC1SMN1; SMN2RAB9AALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 NPC1 919/4885SMN1; SMN2 761/4885RAB9A 1728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.